
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analogue conjugated to a reactive linker that binds serum albumin, extending half-life for sustained GH axis research.
For laboratory and research use only. Not for human or veterinary use.
DAC conjugation enables albumin binding, prolonging circulation time and producing sustained GHRH receptor activation compared to the non-DAC form.
| sequence | GHRH analogue + DAC conjugate |
| molecular Weight | ~3647 Da |
| appearance | White lyophilized powder |
Reconstitute with bacteriostatic water under sterile conditions.
Lyophilized: 2–8 °C. Reconstituted: refrigerate.
Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.